RRM2 is implicated in the progression of various cancers, including breast cancer, lung cancer, liver cancer, kidney cancer, glioma, and pancreatic cancer, among others (71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81). Here, RRM2 is linked to breast carcinoma.